
Serostim: A New Hope for Cachexia in American Males with Chronic Heart Failure
Reading Time: 2 minutes Introduction to Cachexia and Chronic Heart Failure Cachexia, a complex metabolic syndrome associated with underlying illness, is characterized by severe weight loss, muscle atrophy, and a decline in overall quality of life. In patients with chronic heart failure (CHF), cachexia is a prevalent and debilitating condition that significantly increases mortality risk. American males, who are disproportionately affected by CHF, often face the additional burden of cachexia, necessitating innovative treatment approaches. Understanding Serostim and Its Mechanism of Action Serostim, a recombinant human growth hormone (rhGH), has emerged as a potential therapeutic agent for cachexia. By mimicking the action of endogenous growth...